CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | Soffer Donald M Director | Purchase | +100,000 | $10.00 | $1.0M | 153,514 |
| 2021-02-12 | Hare Joshua Chief Scientific Officer | Purchase | +102,000 | $10.00 | $1.0M | 7,997,428 |
| 2021-02-12 | Hare Joshua Chief Scientific Officer | Purchase | +1,000 | $8.23 | $8K | 7,998,428 |
| 2021-02-11 | Borger Erin Director | Returned to the company | −5,000 | 0 | ||
| 2021-02-11 | Ross Cathy Director | Grant or award | +5,000 | 5,000 | ||
| 2021-02-11 | Borger Erin Director | Grant or award | +5,000 | 5,000 | ||
| 2021-02-11 | LOSORDO DOUGLAS W Director | Grant or award | +5,000 | 5,000 |
Page 15 of 15 · 287 trades